Published in J Pediatr on March 01, 1995
Reduction of risk for cardiovascular disease in children and adolescents. Circulation (2011) 1.26
Evaluation of AAP guidelines for cholesterol screening in youth: Project HeartBeat! Am J Prev Med (2009) 0.85
Glycolipid metabolic status of overweight/obese adolescents aged 9- to 15-year-old and the BMI-SDS/BMI cut-off value of predicting dyslipidemiain boys, Shanghai, China: a cross-sectional study. Lipids Health Dis (2013) 0.85
Hereditary dyslipidemias and combined risk factors in children with a family history of premature coronary artery disease. Arch Dis Child (2000) 0.77
A systematic review and meta-analysis on screening lipid disorders in the pediatric age group. J Res Med Sci (2015) 0.77
The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med (1993) 4.61
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
Behavior problems in children before first recognized seizures. Pediatrics (2001) 2.18
Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation (2001) 2.17
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation (1999) 1.87
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA (1999) 1.70
The Cincinnati Lipid Research Clinic family study: cultural and biological determinants of lipids and lipoprotein concentrations. Am J Hum Genet (1982) 1.64
Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (1999) 1.60
Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene. Ann Intern Med (1996) 1.56
Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys. J Pediatr (1999) 1.41
Pubertal staging in boys. J Pediatr (1995) 1.31
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism (1984) 1.29
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest (1986) 1.28
Sexual maturation and obesity in 9- and 10-year-old black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (1994) 1.26
The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism (1985) 1.23
Characterization of the precipitants of hospitalization for heart failure decompensation. Am J Crit Care (1998) 1.21
Longitudinal study of adaptation to the stress of bone marrow transplantation. J Clin Oncol (2000) 1.20
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol (1998) 1.18
Psychosocial variables and hospitalization in persons with chronic heart failure. Prog Cardiovasc Nurs (1997) 1.17
Two-dimensional electrophoresis of human plasma apolipoproteins. Clin Chem (1984) 1.17
Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest (1990) 1.16
Hormonal studies and physical maturation in adolescent gynecomastia. J Pediatr (1990) 1.14
Symptoms of depression in adolescents with epilepsy. J Am Acad Child Adolesc Psychiatry (1999) 1.11
Risk factors for nonelective hospital readmissions. J Gen Intern Med (1996) 1.09
Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. Biochim Biophys Acta (2000) 1.07
Parent-offspring and sibling lipid and lipoprotein associations during and after sharing of household environments: the Princeton school district family study. Metabolism (1982) 1.07
Academic achievement in children with epilepsy or asthma. Dev Med Child Neurol (1998) 1.03
Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol (1997) 1.02
Behaviour problems in children with new-onset epilepsy. Seizure (1997) 1.02
Cardiac rehabilitation participation patterns in a large, tertiary care center: evidence for selection bias. J Cardiopulm Rehabil (2000) 1.02
Adolescents with active or inactive epilepsy or asthma: a comparison of quality of life. Epilepsia (1996) 0.99
Childhood epilepsy and asthma: changes in behavior problems related to gender and change in condition severity. Epilepsia (2000) 0.98
Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation (1994) 0.97
Analysis of the apoC-II gene in apoC-II deficient patients. Biochem Biophys Res Commun (1984) 0.94
Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol (2000) 0.93
Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975-1990: the Princeton School Study. Am J Public Health (1999) 0.92
Does academic achievement in children with epilepsy change over time? Dev Med Child Neurol (1999) 0.92
Familial aggregation of lipids and lipoproteins in families ascertained through random and nonrandom probands in the Iowa Lipid Research Clinics family study. Hum Hered (1991) 0.92
Serum glutathione in adolescent males predicts parental coronary heart disease. Circulation (1999) 0.91
Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study. Circulation (1986) 0.91
Sleep disturbance and HMG CoA reductase inhibitors. JAMA (1990) 0.90
Beliefs about medication and dietary compliance in people with heart failure: an instrument development study. Heart Lung (1997) 0.89
Quality of life in women with heart failure. Health Care Women Int (1998) 0.89
Human preproapolipoprotein C-II. Analysis of major plasma isoforms. J Biol Chem (1986) 0.89
Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia. Biochim Biophys Acta (1989) 0.88
High-density lipoprotein cholesterol in blacks and whites: potential ramifications for coronary heart disease. Am Heart J (1984) 0.88
Lipids, lipoproteins, and sexual maturation during adolescence: the Princeton maturation study. Metabolism (1979) 0.88
Estimation of VLDL cholesterol in hyperlipidemia. Clin Chim Acta (1985) 0.87
In vitro color flow, pulsed and continuous wave Doppler ultrasound masking of flow by prosthetic valves. J Am Coll Cardiol (1987) 0.86
Heterogeneity between populations for multifactorial inheritance of plasma lipids. Am J Hum Genet (1983) 0.86
Multivariate analysis of lipoprotein cholesterol fractions. Am J Epidemiol (1987) 0.86
Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol (1994) 0.86
HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from The Cleveland Clinic Foundation. Circulation (2000) 0.85
Parent-offspring and sibling body mass index associations during and after sharing of common household environments: the Princeton School District Family Study. Metabolism (1983) 0.85
Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age. Arch Dermatol (1991) 0.84
A genetic study of hypoalphalipoproteinemia. Genet Epidemiol (1984) 0.84
Prevalence of familial hyper- and hypolipoproteinemias: the Princeton School District Family Study. Metabolism (1982) 0.84
The Cincinnati Myocardial Infarction and Hormone Family Study: family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families. Metabolism (1993) 0.84
Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia. Am J Cardiol (1986) 0.84
Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect. Biochem Biophys Res Commun (1990) 0.83
The Clinical Lipid Research Clinic Family Study: familial determinants of plasma uric acid. Hum Genet (1982) 0.83
Heterogeneity in the familial aggregation of fasting serum uric acid level in five North American populations: the Lipid Research Clinics Family Study. Am J Med Genet (1990) 0.82
Familial obesity and leanness. Int J Obes (1983) 0.82
Male-female differences in the relationship between obesity and lipids/lipoproteins. Int J Obes Relat Metab Disord (1996) 0.82
Behavioural adjustment and parental stress associated with closed head injury in children. Brain Inj (1996) 0.81
A major gene for primary hypoalphalipoproteinemia. Am J Hum Genet (1986) 0.81
Longitudinal relationships among endogenous testosterone, estradiol, and Quetelet index with high and low density lipoprotein cholesterols in adolescent boys. Pediatr Res (1983) 0.81
The new food label, type of fat, and consumer choice. A pilot study. Arch Fam Med (1994) 0.81
Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents. J Pediatr (1998) 0.80
A simulation study of parameter estimation in the one and two compartment models. J Pharmacokinet Biopharm (1982) 0.80
Triglyceride and high-density lipoprotein cholesterol: predicting disorders in parents from their children. Pediatrics (1994) 0.80
Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat. Am J Dis Child (1993) 0.80
Intrafamilial associations of lipids and lipoproteins in kindreds with hypertriglyceridemic probands: the Princeton School family Study. Circulation (1982) 0.80
The conjoint trait of low high-density lipoprotein cholesterol and high triglycerides in adolescent black and white males. Metabolism (1998) 0.80
Heterogeneity in the biological and cultural determinants of high-density lipoprotein cholesterol in five North American populations: the Lipid Research Clinics Family Study. Hum Hered (1989) 0.79
Commingling and complex segregation analysis of fasting plasma glucose in the Lipid Research Clinics family study. Am J Med Genet (1992) 0.79
A novel test for the measurement of skin cholesterol. Clin Chem (2001) 0.79
Intrafamilial associations of cholesterol and triglyceride among related and unrelated household members. Clin Genet (1980) 0.78
Familial associations of lipids and lipoproteins in families of hypercholesterolemic probands. Arteriosclerosis (1982) 0.78
The Cincinnati Lipid Research Clinic Family Study: analysis of commingling and family resemblance for fasting blood glucose. Genet Epidemiol (1984) 0.78
The effects of three serotypes of Ureaplasma urealyticum on spermatozoal motility and penetration in vitro. Fertil Steril (1991) 0.78
Sex hormones and lipoproteins in adolescent male offspring of parents with premature coronary heart disease and a control group. J Pediatr (1998) 0.78
Familial aggregation of lipids and lipoproteins in families ascertained through random and nonrandom probands in the Stanford Lipid Research Clinics Family Study. Am J Med Genet (1991) 0.78
Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis. Atherosclerosis (2000) 0.78
Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting. J Heart Valve Dis (2001) 0.78
Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study. Circulation (1986) 0.77
Neomycin and plasma lipoproteins in type II hyperlipoproteinemia. Clin Pharmacol Ther (1984) 0.77
Family resemblance for plasma lipids and lipoprotein concentrations in blacks. Cincinnati Lipid Research Clinic Family Study. Arteriosclerosis (1984) 0.77
High and low density lipoprotein cholesterols in adolescent boys: relationships with endogenous testosterone, estradiol, and Quetelet index. Metabolism (1983) 0.77
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin. Circulation (1984) 0.77
Cincinnati myocardial infarction and hormone family study: family resemblance for testosterone in random and MI families. Am J Med Genet (1993) 0.76
Estradiol and testosterone effects on lipids in black and white boys aged 10 to 15 years. Metabolism (2000) 0.76